276 related articles for article (PubMed ID: 16505382)
21. Toxin insights into nicotinic acetylcholine receptors.
Dutertre S; Lewis RJ
Biochem Pharmacol; 2006 Sep; 72(6):661-70. PubMed ID: 16716265
[TBL] [Abstract][Full Text] [Related]
22. Multiple interaction regions in the orthosteric ligand binding domain of the α7 neuronal nicotinic acetylcholine receptor.
Xiao Y; Hammond PS; Mazurov AA; Yohannes D
J Chem Inf Model; 2012 Nov; 52(11):3064-73. PubMed ID: 23092444
[TBL] [Abstract][Full Text] [Related]
23. Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors.
Hansen SB; Taylor P
J Mol Biol; 2007 Jun; 369(4):895-901. PubMed ID: 17481657
[TBL] [Abstract][Full Text] [Related]
24. Atypical alpha-conotoxin LtIA from Conus litteratus targets a novel microsite of the alpha3beta2 nicotinic receptor.
Luo S; Akondi KB; Zhangsun D; Wu Y; Zhu X; Hu Y; Christensen S; Dowell C; Daly NL; Craik DJ; Wang CI; Lewis RJ; Alewood PF; Michael McIntosh J
J Biol Chem; 2010 Apr; 285(16):12355-66. PubMed ID: 20145249
[TBL] [Abstract][Full Text] [Related]
25. Molecular docking study on the α3β2 neuronal nicotinic acetylcholine receptor complexed with α-conotoxin GIC.
Lee C; Lee SH; Kim DH; Han KH
BMB Rep; 2012 May; 45(5):275-80. PubMed ID: 22617450
[TBL] [Abstract][Full Text] [Related]
26. Alpha-conotoxins ImI and ImII target distinct regions of the human alpha7 nicotinic acetylcholine receptor and distinguish human nicotinic receptor subtypes.
Ellison M; Gao F; Wang HL; Sine SM; McIntosh JM; Olivera BM
Biochemistry; 2004 Dec; 43(51):16019-26. PubMed ID: 15609996
[TBL] [Abstract][Full Text] [Related]
27. Hydrophobic residues at position 10 of α-conotoxin PnIA influence subtype selectivity between α7 and α3β2 neuronal nicotinic acetylcholine receptors.
Hopping G; Wang CI; Hogg RC; Nevin ST; Lewis RJ; Adams DJ; Alewood PF
Biochem Pharmacol; 2014 Oct; 91(4):534-42. PubMed ID: 25101833
[TBL] [Abstract][Full Text] [Related]
28. Design and synthesis of α-conotoxin GID analogues as selective α4β2 nicotinic acetylcholine receptor antagonists.
Banerjee J; Yongye AB; Chang YP; Gyanda R; Medina-Franco JL; Armishaw CJ
Biopolymers; 2014 Jan; 102(1):78-87. PubMed ID: 24122487
[TBL] [Abstract][Full Text] [Related]
29. Binding mode of alpha-conotoxins to an acetylcholine binding protein determined by saturation transfer difference NMR.
Westermann JC; Clark RJ; Craik DJ
Protein Pept Lett; 2008; 15(9):910-4. PubMed ID: 18991766
[TBL] [Abstract][Full Text] [Related]
30. The 2.7 A structure of AChBP, homologue of the ligand-binding domain of the nicotinic acetylcholine receptor.
Brejc K; van Dijk WJ; Smit AB; Sixma TK
Novartis Found Symp; 2002; 245():22-9; discussion 29-32, 165-8. PubMed ID: 12027010
[TBL] [Abstract][Full Text] [Related]
31. Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations.
Hansen SB; Sulzenbacher G; Huxford T; Marchot P; Taylor P; Bourne Y
EMBO J; 2005 Oct; 24(20):3635-46. PubMed ID: 16193063
[TBL] [Abstract][Full Text] [Related]
32. Key Structural Determinants in the Agonist Binding Loops of Human β2 and β4 Nicotinic Acetylcholine Receptor Subunits Contribute to α3β4 Subtype Selectivity of α-Conotoxins.
Cuny H; Kompella SN; Tae HS; Yu R; Adams DJ
J Biol Chem; 2016 Nov; 291(45):23779-23792. PubMed ID: 27646000
[TBL] [Abstract][Full Text] [Related]
33. An allosteric binding site of the α7 nicotinic acetylcholine receptor revealed in a humanized acetylcholine-binding protein.
Delbart F; Brams M; Gruss F; Noppen S; Peigneur S; Boland S; Chaltin P; Brandao-Neto J; von Delft F; Touw WG; Joosten RP; Liekens S; Tytgat J; Ulens C
J Biol Chem; 2018 Feb; 293(7):2534-2545. PubMed ID: 29237730
[TBL] [Abstract][Full Text] [Related]
34. Investigation of α-conotoxin unbinding using umbrella sampling.
Yu R; Tabassum N; Jiang T
Bioorg Med Chem Lett; 2016 Feb; 26(4):1296-300. PubMed ID: 26796065
[TBL] [Abstract][Full Text] [Related]
35. Alpha-RgIA, a novel conotoxin that blocks the alpha9alpha10 nAChR: structure and identification of key receptor-binding residues.
Ellison M; Feng ZP; Park AJ; Zhang X; Olivera BM; McIntosh JM; Norton RS
J Mol Biol; 2008 Apr; 377(4):1216-27. PubMed ID: 18295795
[TBL] [Abstract][Full Text] [Related]
36. alpha-Conotoxin GI benzoylphenylalanine derivatives. (1)H-NMR structures and photoaffinity labeling of the Torpedo californica nicotinic acetylcholine receptor.
Kasheverov IE; Chiara DC; Zhmak MN; Maslennikov IV; Pashkov VS; Arseniev AS; Utkin YN; Cohen JB; Tsetlin VI
FEBS J; 2006 Apr; 273(7):1373-88. PubMed ID: 16689926
[TBL] [Abstract][Full Text] [Related]
37. NMR solution structure of alpha-conotoxin ImI and comparison to other conotoxins specific for neuronal nicotinic acetylcholine receptors.
Rogers JP; Luginbühl P; Shen GS; McCabe RT; Stevens RC; Wemmer DE
Biochemistry; 1999 Mar; 38(13):3874-82. PubMed ID: 10194298
[TBL] [Abstract][Full Text] [Related]
38. Toward atomic-scale understanding of ligand recognition in the muscle nicotinic receptor.
Sine SM; Wang HL; Gao F
Curr Med Chem; 2004 Mar; 11(5):559-67. PubMed ID: 15032604
[TBL] [Abstract][Full Text] [Related]
39. Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors.
Tsetlin V; Utkin Y; Kasheverov I
Biochem Pharmacol; 2009 Oct; 78(7):720-31. PubMed ID: 19501053
[TBL] [Abstract][Full Text] [Related]
40. Structure and function of AChBP, homologue of the ligand-binding domain of the nicotinic acetylcholine receptor.
Smit AB; Brejc K; Syed N; Sixma TK
Ann N Y Acad Sci; 2003 Sep; 998():81-92. PubMed ID: 14592865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
